Levonorgestrel News and Research

RSS

Hormonal contraceptives and breast cancer: what's the risk?

The current study, reported in the PLOS Medicine journal, explored breast cancer risk linked to the current or past use of hormonal contraception during the reproductive period in women.

26 Mar 2023

IUDs work at least as well as tubal ligation at preventing pregnancies, study says

IUDs work at least as well as tubal ligation, while causing fewer side effects, according to a new study.

23 Feb 2022

WHO recommends the use of first long-acting option to protect women from HIV

The first long-acting option to protect women from HIV, proven to reduce women's HIV risk, has been recommended for use by the World Health Organization.

1 Dec 2021

IUDs appear to have systemic effects on the body, breast MRI study shows

Intrauterine contraceptive devices (IUDs) appear to have systemic effects on the body like those of hormone replacement therapy, according to a breast MRI study being presented next week at the annual meeting of the Radiological Society of North America.

22 Nov 2021

Study shows that breast cancer can be prevented with better contraception choices

Hormonal contraceptives, e.g. the pill, the patch, and the vaginal ring, contain synthetic hormones that prevent pregnancy by either stopping ovulation, changing the cervical mucus to stop sperm from passing through the cervix and finding an egg, or changing the womb's lining to prevent a fertilized egg from being implanted in it.

29 May 2021

Access to emergency contraception can help reduce unintended pregnancy in teens

About 22 percent of women between the ages of 15 and 44 report having used emergency contraception. But even though the Food and Drug Administration approved levonorgestrel--more commonly known as Plan B--for over-the-counter use for women of all ages in 2013, it's not always easy to get--especially at local, mom-and-pop drug stores.

30 Sep 2020

Patients using copper IUDs have lower cervical cancer risk compared to LNG-IUS users

Patients who used copper intrauterine devices (Cu IUD) were found to have a lower risk of high-grade cervical neoplasms (cervical cancer) compared to users of the levonorgestrel-releasing intrauterine system (LNG-IUS), according to a Columbia study recently published in Obstetrics & Gynecology.

10 Mar 2020

A 'once a month' birth control pill

Birth control pills in their present form need to be taken once a day each day for the whole menstrual cycle. Other options such as Intra-Uterine devices (IUDs) or implanted progesterone offer a longer coverage, but most women prefer the pills due to their reliability and cheaper, easier and safer usage profile.

5 Dec 2019

Long-acting contraceptives do not increase risk of HIV, concludes new study

One of the largest and most robust studies on HIV infection rates has concluded that long-acting contraceptives do not increase the risk of contracting HIV.

14 Jun 2019

Contraceptive jewelry may be new approach to family planning for women

Family planning for women might one day be as simple as putting on an earring.

27 Mar 2019

Buffalo researchers receive grant to quicken development of generic equivalents of contraceptives

University at Buffalo researchers received an $880,000 grant to help quicken the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus, such as by intrauterine devices

21 Jan 2019

Combe announces launch of Preventeza Emergency Contraceptive and campaign

Combe Inc., the makers of Vagisil, today announced the launch of its Preventeza Emergency Contraceptive #WeAre1in2 campaign to showcase solidarity around women's reproductive rights.

6 Jul 2018

Researchers identify barriers to emergency contraception access in retail pharmacies

Efforts to remove barriers to accessing emergency contraception (EC) scored victories in 2013, when the U.S. Food and Drug Administration removed age restrictions on over-the-counter sales of the levonogestrel drug Plan B. But those who need EC can still encounter cost and availability barriers.

22 Sep 2017

Early placement of hormonal IUD does not negatively affect breastfeeding or lactation

Having a hormonal intrauterine device (IUD) implanted immediately after birth does not affect a woman's ability to lactate and breastfeed, according to new research by investigators at University of Utah Health and University of New Mexico School of Medicine.

26 Aug 2017

Oral contraceptive pills have negative impact on women's quality of life, study shows

One of the most common combined oral contraceptive pills has a negative impact on women's quality of life but does not increase depressive symptoms.

18 Apr 2017

Treating PCOS in adolescent girls may help prevent future subfertility, research suggests

In adolescent girls with polycystic ovary syndrome (PCOS), bringing the amount of abdominal visceral fat and liver fat down to normal restores ovulation, normalizes the symptoms of androgen excess, and may help prevent future subfertility, new research from Spain suggests.

4 Apr 2017

Clinical trial finds women with heavy periods can be greatly helped by GP-prescribed treatments

The largest and longest running clinical trial of medical therapies for heavy periods has found that women can be greatly helped by having treatments just from their GP, with most avoiding hospital operations.

12 Oct 2016

Hormonal contraception may increase susceptibility of women to genital infection

Women account for approximately half of all individuals living with HIV worldwide, and researchers wanted to identify the risk factors that increase susceptibility of women to genital infection.

20 Apr 2016

New study provides biological explanation for how DMPA increases risk of HIV infection

In recent years, evidence has been building that injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera or DMPA) is associated with an increased risk of HIV infection. Now a study published in the September 1st issue of mBio, an online open-access journal of the American Society for Microbiology, provides a biological explanation for the phenomenon.

2 Sep 2015

Mylan releases generic version of Seasonale Tablets in the U.S.

Mylan N.V. today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, which is the generic version of Teva's Seasonale Tablets. Mylan's partner Famy Care Ltd. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

5 May 2015